AnodyneWiki

Atomoxetine

Atomoxetine
Atomoxetine
Salts
[]
Atomoxetine hydrochloride
Atomoxetine hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass255.35 g/mol [1]
Melting point161-165 ºC [1]
Boiling point64-65 ºC at 0.760 mmHg [1]
Solubility27.8 mg/mL [1]
Predicted LogP3.7 [1]
Structural Identifiers
[]
Molecular formulaC17H21NO
IUPAC name(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine
SMILESCC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2
InChIInChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1
InChIKeyVHGCDTVCOLNTBX-QGZVFWFLSA-N
CAS number83015-26-3
UNIIASW034S0B8
PubChem CID54841
Pharmacokinetics[]
Onset1–2 hours (time to peak levels)
Elimination half-lifeCYP2D6 extensive metabolizers: 4.5–5.3 h, CYP2D6 poor metabolizers: 19–22 h
MetabolismLiver: ring hydroxylation (CYP2D6, others), benzylic hydroxylation, N-demethylation (CYP2C19), glucuronidation (UDP-glucuronyltransferases)
ExcretionCYP2D6 extensive metabolizers: urine (>96%), feces (1–2%), CYP2D6 poor metabolizers: urine (80%), feces (13–22%)
Routes of administrationOral
Dosing[]
Oral
[]
Light≤ 25 mg(8x - 66.7%)
Common25 mg
Strong25 - 50 mg(4x - 33.3%)
Heavy50 mg
Extreme50 mg +
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki)
We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly.

Atomoxetine (also known as Tomoxetine, (-)-Tomoxetine, Tomoxetina, Tomoxetinum, Tomoxetinum [Latin], Atomoxetina, atomoxetinum, methyl[(3R)-3-(2-methylphenoxy)-3-phenylpropyl]amine, Tomoxetinum (Latin) or Ad313 component atomoxetine) is a substance of the phenylpropylamine class.

Chemistry

Salts []

Atomoxetine is typically found in the form of its hydrochloride salt.

 []

Atomoxetine is a single defined stereoisomer (optical activity ( - )).

Atomoxetine matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Atomoxetine is known to be a potent and selective inhibitor of the norepinephrine transporter (NET), which prevents cellular reuptake of norepinephrine throughout the brain, which is thought to improve the symptoms of ADHD. More recently, positron emission tomography (PET) imaging studies in rhesus monkeys have shown that atomoxetine also binds to the serotonin transporter (SERT), and blocks the N-methyl-d-aspartate (NMDA) receptor, indicating a role for the glutamatergic system in the pathophysiology of ADHD. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / inhibition / induction141 (6 contraindicated)
shared target43

Medical side effects []

162 side effects listed on drug labels in (atomoxetine).

  • Dry mouth
  • Abdominal pain upper
  • Headache
  • Abdominal pain
  • Gastrointestinal pain
  • Middle insomnia
  • Tachycardia
  • Abdominal discomfort
  • Upset stomach
  • Blood pressure increased
  • Epigastric discomfort
  • Insomnia
  • Decreased appetite
  • Anorexia
  • Nausea
  • Cough
  • Vomiting
  • Asthenia
  • Fatigue
  • Dysuria
  • Strangury
  • Somnolence
  • Erectile dysfunction
  • Dizziness
  • Syncope
  • Dysmenorrhoea
  • Irritability
  • Sinusitis
  • Vertigo
  • Urinary hesitation
  • Mydriasis
  • Pruritus
  • Urinary retention
  • Depressive symptom
  • Dysphoria
  • Ejaculation failure
  • Initial insomnia
  • Terminal insomnia
  • Major depression
  • Libido decreased
  • Disturbance in sexual arousal
  • Dermatitis
  • Rash
  • Dyspepsia
  • Hyperhidrosis
  • Sweating increased
  • Abnormal dreams
  • Ejaculation disorder
  • Nasopharyngitis
  • Rhinorrhoea
  • Diarrhoea
  • Body temperature increased
  • Influenza
  • Menstrual disorder
  • Palpitations
  • Paraesthesia
  • Prostatitis
  • Sinus headache
  • Chills
  • Rigors
  • Myalgia
  • Musculoskeletal discomfort
  • Arthralgia
  • Ejaculation delayed
  • Menopausal symptoms
  • Hot flush
  • Ear infection
  • Sleep disorder
  • Constipation
  • Flatulence
  • Orgasm abnormal
  • Thirst
  • Tremor
  • Weight decreased
  • Mood swings
  • Affect lability
  • Menstruation irregular
  • Menstruation delayed
  • Nervousness
  • Feeling jittery
  • Therapeutic response unexpected
  • Conjunctivitis
  • Flushing
  • Sinus tachycardia
  • Presyncope
  • Aggression
  • Anxiety
  • Mental disorder
  • Coma
  • Delirium
  • Depression
  • Hallucination
  • Hostility
  • Hypoaesthesia
  • Lethargy
  • Muscle rigidity
  • Myoclonus
  • Nervous system disorder
  • Neuroleptic malignant syndrome
  • Pelvic pain
  • Psychotic disorder
  • Convulsion
  • Suicide attempt
  • Shock
  • Loss of consciousness
  • Angiopathy
  • Agitation
  • Skin disorder
  • Autonomic nervous system imbalance
  • Mania
  • Depressed mood
  • Suicidal ideation
  • Genital pain
  • Drug interaction
  • Completed suicide
  • Mental status changes
  • Erection increased
  • Pre-existing disease
  • Back pain
  • Bone disorder
  • Breast disorder
  • Chest pain
  • Infection
  • Drug abuse
  • Dysgeusia
  • Excoriation
  • Gastrointestinal disorder
  • Gastrointestinal symptom NOS
  • Cardiac disorder
  • Mediastinal disorder
  • Nasal congestion
  • Tension
  • Pain
  • Muscle spasms
  • Testicular pain
  • Upper respiratory tract infection
  • Urethral disorder
  • Urinary tract disorder
  • Urticaria
  • Pollakiuria
  • Micturition urgency
  • Sinus congestion
  • Viral diarrhoea
  • Malnutrition
  • Disorientation
  • Abnormal behaviour
  • Oropharyngeal discomfort
  • Oropharyngeal pain
  • Peripheral coldness
  • Drug dependence
  • Vision blurred
  • Crying
  • Tearfulness
  • Dependence
  • Urine flow decreased
  • Sexual dysfunction
  • Infestation
  • Laryngeal pain
  • Female sexual dysfunction
  • Hepatic failure
  • Feeling abnormal
  • Suicidal behaviour

Indications

  • Agitation
  • Angle closure glaucoma
  • Attention deficit disorder
  • Attention deficit/hyperactivity disorder
  • Body temperature increased
  • Coma
  • Delirium
  • Epilepsy
  • Forgetfulness
  • Hepatic insufficiency
  • Hyperkinesia
  • Hypersensitivity
  • Mental disorder
  • Mental status changes
  • Muscle rigidity
  • Mydriasis
  • Myoclonus
  • Neuroleptic malignant syndrome
  • Psychotic disorder

Subjective effects []

a1ko / Atomoxetine []
Routes:
  • Oral
  • Insufflated
Pilz / Atomoxetine []
Routes:
  • Oral (10mg)
Forms:
  • Hydrochloride
Source:Notes:
  • No effects noted at 10mg

Experience reports

Reddit

There are currently 1 trip reports involving atomoxetine on : []

 []

  • Australia: Atomoxetine is a Schedule 4.
  • Brazil: Atomoxetine is a C1.[3]
  • Canada: Atomoxetine is Prescription only.
  • New Zealand: Atomoxetine is Prescription only.
  • United Kingdom: Atomoxetine is Prescription only.[4]
  • United States: Atomoxetine is Prescription only.
  • European Union: Atomoxetine is Prescription only.[5]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 54841, Atomoxetine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/54841
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Atomoxetine. UNII: ASW034S0B8. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/ASW034S0B8
  3. RDC Nº 816 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 15 September 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-816-de-15-de-setembro-de-2023-510390164
  4. Strattera 10mg hard capsules - Summary of Product Characteristics (SmPC). (emc). 8 February 2021. https://www.medicines.org.uk/emc/product/5531/smpc
  5. Active substance(s): atomoxetine. List of nationally authorised medicinal products. 2016. https://www.ema.europa.eu/en/documents/psusa/atomoxetine-list-nationally-authorised-medicinal-products-psusa/00000262/201511_en.pdf

Data sources []

SourceStatusUpdated (UTC)
dosingok2026-11-20 14:29:51
drugspromissing (no DrugsPRO reagent data)2026-11-20 14:29:47
erowidmissing (no Erowid substance of that name)2026-11-20 14:29:47
gsrsok2026-11-20 14:29:48
hmdbmissing (hmdb.ca refused automated access to HMDB0014434)2026-11-20 14:29:47
keggok2026-11-20 14:29:50
pubchemok2026-11-20 14:29:47
redditok2026-11-20 14:29:47
siderok2026-11-20 14:29:47
structureok2026-11-20 14:29:47
wikipediaok2026-11-20 14:29:47